4.5 Article

Veno-venous extracorporeal membrane oxygenation bridging to pharmacotherapy in pulmonary arterial hypertensive crisis

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 29, 期 7, 页码 811-813

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2010.02.005

关键词

pulmonary arterial hypertension; mechanical circulatory support; right ventricular failure; ECMO; pulmonary hypertension

资金

  1. Actelion Pharmaceuticals
  2. Gilead Sciences
  3. Pfizer
  4. United Therapeutics

向作者/读者索取更多资源

We report the case of a treatment-naive patient with pulmonary arterial hypertension who presented with decompensated right ventricular failure and cardiogenic shock. Unstable hemodynamics, hypoxia and end-organ hypoperfusion limited up-titration of pharmacotherapy. Mechanical circulatory support with veno-venous extracorporeal membrane oxygenation (VV-ECMO) was initiated to permit dose titration of pulmonary vasodilator therapy. VV-ECMO was weaned after 10 days of support, with successful transition to intravenous epoprostenol and oral sildenafil. J Heart Lung Transplant 2010;29:811-3 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据